Vergoeding 2020-2024 voor ATC-subgroep G04CA : Alfa-blokkers
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| G04CA01 Alfuzosine | 847.730 | 787.350 | 784.390 | 811.470 | 816.790 |
| G04CA02 Tamsulosine (Omnic ®) | 2.069.900 | 1.916.200 | 1.947.000 | 1.947.600 | 3.122.800 |
| G04CA03 Terazosine (Hytrin ®) | 55.434 | 17.393 | 14.410 | 9.494 | 12.456 |
| G04CA04 Silodosine (Silodyx ®) | 911.590 | 858.500 | 913.600 | 913.480 | 905.480 |
| G04CA52 Tamsulosine met dutasteride (Combodart ®) | 7.295.100 | 3.223.300 | 2.267.800 | 2.036.100 | 1.974.600 |
| G04CA53 Tamsulosine met solifenacine (Vesomni ®) | 3.545.300 | 3.862.800 | 4.347.000 | 4.655.000 | 4.696.800 |
| Totaal | 14.725.054 | 10.665.543 | 10.274.200 | 10.373.144 | 11.528.926 |